Revolution Medicines, Inc.

RVMDW· Nasdaq

Since Oct 5, 2025

Transactions: 162
Purchases: 0
Sales: 162
Purchase value: $0.00
Sale value: $116.32M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

34 rows are listed but not counted: their filed prices fail a plausibility check, or they are not common stock.

Sandler Alan B.Chief Development Officer

4Rule 10b5-1 plan disclosed

Filed Oct 1, 2026Period of report Sep 29, 20260001835966-26-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleSep 29, 2026	Common Stock^F1^F2	2,200	$200.8188	$441.80K	56,668	Direct
SaleSep 29, 2026	Common Stock^F1^F3	1,609	$201.7239	$324.57K

Filing footnotes · 8

F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
F2The transaction was executed in multiple trades at prices ranging from $200.41 to $201.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3The transaction was executed in multiple trades at prices ranging from $201.41 to $202.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4The transaction was executed in multiple trades at prices ranging from $202.42 to $203.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades at prices ranging from $203.42 to $204.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades at prices ranging from $204.43 to $204.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Open on SEC EDGAR

Cislini JeffSVP & General Counsel

4Rule 10b5-1 plan disclosed

Filed Sep 29, 2026Period of report Sep 25, 20260001969082-26-000011

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 28, 2026Period of report Sep 24, 20260002124509-26-000012

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anderson Elizabeth MDirector

4Rule 10b5-1 plan disclosed

Filed Sep 24, 2026Period of report Sep 22, 20260001758247-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 22, 2026Period of report Sep 18, 20260002124509-26-000010

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260002124509-26-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffSVP & General Counsel

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001969082-26-000009

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Sandler Alan B.Chief Development Officer

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001835966-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001800668-26-000007

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kelsey Stephen MichaelSee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001462808-26-000010

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001294192-26-000007

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 16, 20260001246842-26-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kelsey Stephen MichaelSee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 15, 2026Period of report Sep 11, 20260001462808-26-000007

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Sep 14, 2026Period of report Sep 10, 20260002124509-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kim Lorence H.Director

4Rule 10b5-1 plan disclosed

Filed Sep 10, 2026Period of report Sep 8, 20260001193125-26-388156

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kim Lorence H.Director

4Rule 10b5-1 plan disclosed

Filed Sep 2, 2026Period of report Aug 31, 20260001193125-26-380277

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffGeneral Counsel

4Rule 10b5-1 plan disclosed

Filed Aug 25, 2026Period of report Aug 21, 20260001610717-26-000388

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Aug 25, 2026Period of report Aug 21, 20260001610717-26-000387

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Patel SushilDirector

4Rule 10b5-1 plan disclosed

Filed Jul 1, 2026Period of report Jun 29, 20260001610717-26-000311

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Jun 26, 2026Period of report Jun 24, 20260001610717-26-000296

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Jun 17, 2026Period of report Jun 15, 20260001610717-26-000230

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

Filed Jun 18, 2026Period of report Jun 16, 20260001610717-26-000247

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJun 16, 2026	Common Stock^F1^F2^F3^F4	4,615	$156.1192

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Jun 18, 2026Period of report Jun 16, 20260001610717-26-000246

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffGeneral Counsel

4Rule 10b5-1 plan disclosed

Filed Jun 18, 2026Period of report Jun 16, 20260001610717-26-000245

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Jun 18, 2026Period of report Jun 16, 20260001610717-26-000244

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kelsey Stephen MichaelSee Remarks

4Rule 10b5-1 plan disclosed

Filed Jun 18, 2026Period of report Jun 16, 20260001610717-26-000243

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Jun 15, 2026Period of report Jun 11, 20260001610717-26-000216

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed May 28, 2026Period of report May 26, 20260001610717-26-000166

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Apr 29, 2026Period of report Apr 27, 20260001610717-26-000158

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Apr 17, 2026Period of report Apr 15, 20260001610717-26-000146

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Mancini AnthonySee Remarks

4Rule 10b5-1 plan disclosed

Filed Mar 26, 2026Period of report Mar 25, 20260001610717-26-000137

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffGeneral Counsel

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000127

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Wei LinChief Medical Officer

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000132

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kelsey Stephen MichaelSee Remarks

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000131

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000130

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000129

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000128

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Wang XiaolinSee Remarks

4Rule 10b5-1 plan disclosed

Filed Mar 19, 2026Period of report Mar 17, 20260001610717-26-000126

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Mar 3, 2026Period of report Mar 1, 20260001610717-26-000082

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffGeneral Counsel

4Rule 10b5-1 plan disclosed

Filed Jan 23, 2026Period of report Jan 21, 20260001610717-26-000018

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Jan 9, 2026Period of report Jan 7, 20260001610717-26-000013

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Jan 9, 2026Period of report Jan 7, 20260001610717-26-000012

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Cislini JeffGeneral Counsel

4Rule 10b5-1 plan disclosed

Filed Dec 18, 2025Period of report Dec 16, 20250001610717-25-000424

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Dec 18, 2025Period of report Dec 16, 20250001610717-25-000423

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Kelsey Stephen MichaelSee Remarks

4Rule 10b5-1 plan disclosed

Filed Dec 18, 2025Period of report Dec 16, 20250001610717-25-000422

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Horn Margaret AChief Operating Officer

4Rule 10b5-1 plan disclosed

Filed Dec 18, 2025Period of report Dec 16, 20250001610717-25-000421

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Dec 18, 2025Period of report Dec 16, 20250001610717-25-000420

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Anders JackChief Financial Officer

4Rule 10b5-1 plan disclosed

Filed Nov 26, 2025Period of report Nov 25, 20250001610717-25-000404

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Nov 26, 2025Period of report Nov 25, 20250001610717-25-000403

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Goldsmith Mark aDirector · See Remarks

4Rule 10b5-1 plan disclosed

Filed Nov 20, 2025Period of report Nov 18, 20250001610717-25-000384

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.

Filing footnotes · 9

F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 23, 2026.
F2The transaction was executed in multiple trades at prices ranging from $191.65 to $191.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3The transaction was executed in multiple trades at prices ranging from $192.01 to $192.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4The transaction was executed in multiple trades at prices ranging from $193.00 to $193.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades at prices ranging from $194.04 to $194.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6Includes 1,191 restricted stock units.
F7Held by David W. Anderson 1996 Irrevocable Trust.
F8Held by Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson.
F9Fully vested.

Filing footnotes · 12

F1Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026.
F10Includes 76,251 restricted stock units.
F11Fully vested.
F12One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2The transaction was executed in multiple trades at prices ranging from $198.35 to $198.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3The transaction was executed in multiple trades at prices ranging from $199.36 to $200.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4The transaction was executed in multiple trades at prices ranging from $200.36 to $201.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades at prices ranging from $201.39 to $202.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades at prices ranging from $202.41 to $203.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7The transaction was executed in multiple trades at prices ranging from $203.45 to $204.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8The transaction was executed in multiple trades at prices ranging from $204.46 to $205.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9The transaction was executed in multiple trades at prices ranging from $205.57 to $206.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing footnotes · 8

F1Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
F2The transaction was executed in multiple trades at prices ranging from $202.64 to $203.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3The transaction was executed in multiple trades at prices ranging from $203.64 to $204.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4The transaction was executed in multiple trades at prices ranging from $204.64 to $205.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades at prices ranging from $205.85 to $206.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades at prices ranging from $207.12 to $207.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7Includes 43,700 restricted stock units.
F8Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Filing footnotes · 10

F1Includes 1,191 restricted stock units.
F10The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F2Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.
F3The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4Shares held by the Lorence Kim Revocable Trust.
F5The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing footnotes · 9

F1Includes 1,191 restricted stock units.
F2Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.
F3Shares held by the Lorence Kim Revocable Trust (the "Trust"). Of the 73,090 shares held by the Trust immediately prior to the transactions reported herein, 50,000 shares were acquired by the Trust in July 2022 and were previously reported as directly owned by the Reporting Person, and 23,090 shares were transferred by the Reporting Person to the Trust in August 2025. The August 2025 transfer effected only a change in the form of beneficial ownership without a change in the Reporting Person's pecuniary interest and was exempt pursuant to Rule 16a-13.
F4The transaction was executed in multiple trades at prices ranging from $201.00 to $201.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades at prices ranging from $202.00 to $202.9956, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades at prices ranging from $203.0055 to $203.9968, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7The transaction was executed in multiple trades at prices ranging from $204.00 to $204.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8The transaction was executed in multiple trades at prices ranging from $205.00 to $205.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9The transaction was executed in multiple trades at prices ranging from $206.02 to $206.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing footnotes · 9

F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
F2Includes 43,514 restricted stock units.
F3This transaction was executed in multiple trades in prices ranging from $206.76 to $207.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4This transaction was executed in multiple trades in prices ranging from $207.765 to $208.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5This transaction was executed in multiple trades in prices ranging from $208.77 to $209.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6This transaction was executed in multiple trades in prices ranging from $209.77 to $210.72, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7This transaction was executed in multiple trades in prices ranging from $210.77 to $211.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8This transaction was executed in multiple trades in prices ranging from $211.77 to $212.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from September 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Filing footnotes · 19

F1Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
F10Held by Jonathan Goldsmith Revocable Trust.
F11This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F12This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F13This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F14This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F15This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F16Held by Rebecca Goldsmith Revocable Trust.
F17This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F18This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F19Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F2Includes 182,938 restricted stock units.
F3This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing footnotes · 11

F1Transaction made pursuant to a 10b5-1 trading plan adopted by Sushil Patel on March 30, 2026.
F10The transaction was executed in multiple trades in prices ranging from $192.55 to $192.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F11Fully vested.
F2Includes 1,191 restricted stock units.
F3The transaction was executed in multiple trades in prices ranging from $182.93 to $183.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4The transaction was executed in multiple trades in prices ranging from $184.08 to $184.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5The transaction was executed in multiple trades in prices ranging from $185.37 to $186.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6The transaction was executed in multiple trades in prices ranging from $186.38 to $187.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7The transaction was executed in multiple trades in prices ranging from $187.46to $188.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8The transaction was executed in multiple trades in prices ranging from $190.44 to $190.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9The transaction was executed in multiple trades in prices ranging from $191.47 to $192.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing footnotes · 10

F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
F10One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2Includes 73,050 restricted stock units ("RSUs").
F3This transaction was executed in multiple trades in prices ranging from $160.00 to $160.3550, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of RSUs after July 15, 2023.
F5This transaction was executed in multiple trades in prices ranging from $156.1105 to $156.8250, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6Includes 66,201 RSUs.
F7This transaction was executed in multiple trades in prices ranging from $160.00 to $160.48, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F9One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Filing footnotes · 10

F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
F10One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2Includes 73,050 restricted stock units.
F3Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.
F4This transaction was executed in multiple trades in prices ranging from $143.78 to $144.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5This transaction was executed in multiple trades in prices ranging from $144.79 to $145.61, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6This transaction was executed in multiple trades in prices ranging from $145.88 to $146.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7This transaction was executed in multiple trades in prices ranging from $147.06 to $147.41, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8This transaction was executed in multiple trades in prices ranging from $148.14 to $149.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9This transaction was executed in multiple trades in prices ranging from $149.17 to $150.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing footnotes · 8

F1Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on December 24, 2025.
F2Includes 54,400 Restricted Stock Units.
F3This transaction was executed in multiple trades at prices ranging from $92.69 to $93.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4This transaction was executed in multiple trades at prices ranging from $93.75 to $94.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6This transaction was executed in multiple trades at prices ranging from $96.00 to $96.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7This transaction was executed in multiple trades at prices ranging from $97.12 to $97.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Filing footnotes · 17

F1Includes 225,863 restricted stock units.
F10Held by Jonathan Goldsmith Revocable Trust.
F11This transaction was executed in multiple trades at prices ranging from $99.79 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F12This transaction was executed in multiple trades at prices ranging from $100.81 to $101.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F13This transaction was executed in multiple trades at prices ranging from $101.82 to $102.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F14Held by Rebecca Goldsmith Revocable Trust.
F15This transaction was executed in multiple trades at prices ranging from $99.80 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F16This transaction was executed in multiple trades at prices ranging from $101.07 to $102.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F17One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F2Reflects the transfer of 24,010 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F3Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.
F4This transaction was executed in multiple trades at prices ranging from $97.83 to $98.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5This transaction was executed in multiple trades at prices ranging from $99.12 to $100.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6This transaction was executed in multiple trades at prices ranging from $100.14 to $101.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7This transaction was executed in multiple trades at prices ranging from $101.14 to $102.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8This transaction was executed in multiple trades at prices ranging from $102.14 to $102.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.